TrialReader


Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods

NCT03197896 — Not applicable, Completed, 239 participants, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Neighborhood-Based Intervention to Reduce Prostate Cancer Disparities

RegistryNCT03197896
StatusCompleted
PhaseNot applicable
Study typeInterventional; non randomized, parallel, masking: none, health services research
Enrollment239 (Actual)
SponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (Other); collaborators: United States Department of Defense
ConditionsProstate
InterventionsEducational Intervention (Other)
Datesstart 2016-09-29, primary completion 2018-07-20, completion 2018-07-20, first posted 2017-06-23, last updated 2026-03-25
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Prostate All trials of Educational Intervention

-Summary

This clinical trial studies how well an educational intervention works in increasing knowledge about prostate cancer in high-risk neighborhoods. Learning about prostate cancer and the pros and cons of screening for prostate cancer may increase knowledge about prostate cancer while decreasing anxiety and concerns about prostate cancer screening.

Expand all sections  ·  Collapse all

+Detailed description

PRIMARY OBJECTIVES:

I. To identify neighborhoods with disproportionately high rates of advanced prostate cancer and describe patient- and neighborhood-level risk factors associated with the high-risk neighborhoods.

II. To develop, using a mixed methods approach, a targeted educational intervention about prostate cancer for men who live in high risk neighborhoods.

III. To test the impact of the targeted intervention on levels of knowledge, anxiety, and informed decision making about prostate cancer (PCa) screening.

IV. To observe the rates of PCa screening in the intervention and control groups.

+Arms and interventions

ArmTypeInterventionsDescription
Group I (prostate cancer information)ExperimentalOther: Educational InterventionThe educator reviews general information about the prostate Cancer
Group II (general health information)Active comparatorOther: Educational InterventionThe educator reviews topics about health promotion actions.
  • Educational Intervention (Other): Review prostate cancer information

+Outcome measures

Primary outcomes

  • Change in Prostate Cancer Knowledge as Measured by the Decisional Conflict Scale [4 months]: The Decisional Conflict Scale (DCS) measures uncertainty in health decision-making. It includes 16 items rated on a 5-point Likert scale. Scores are calculated by averaging item responses and multiplying by 25, yielding a range from 0 (no conflict) to 100 (high conflict). Lower scores indicate greater clarity, confidence, and satisfaction with the decision. Higher scores reflect uncertainty, lack of information/support, and low confidence. The self-efficacy subscale assesses confidence in decision-making with responses like "a lot confident," "a little confident," or "not at all confident."
  • Intent to Screen for PCa [baseline to 4 months]: Estimated mean changes from baseline assessment in likelihood of screening by study group from baseline to 4 month follow up. Intent to screen for prostate cancer was measured on a 5 point Likert Scale (1= very unlikely to 5=very likely). Results represent estimated mean change and 95% Confidence Interval from baseline in intent-to-screen score.

+Eligibility

Sex: Male, ages: 40 Years to 69 Years

Inclusion Criteria:

* Focus groups consisting of men who live, work, or worship in the 4 predetermined neighborhoods
* Currently reside in one of the four selected high risk neighborhoods

Exclusion Criteria:

• Men who do not reside in one of the four neighborhoods, who self-report that they have previously been diagnosed with prostate cancer, or who have had prostate cancer screening (prostatic specific antigen \[PSA\] or digital rectal examination \[DRE\]) within the past 12 months

+Posted results

Participant flow

MilestoneGroup I (Prostate Cancer Information)Group II (General Health Information)
Started121118
Completed121118
Not completed00

Outcome results

  • Change in Prostate Cancer Knowledge as Measured by the Decisional Conflict Scale (Primary), Median, score on a scale: Group I (Prostate Cancer Information) 80 (40 to 100); Group II (General Health Information) 70 (40 to 100)
  • Intent to Screen for PCa (Primary), Mean, Scores on a Scale (1-5): Group I (Prostate Cancer Information) 0.91 (0.49 to 1.32); Group II (General Health Information) 0.78 (0.40 to 1.16)

Adverse events

Time frame: reporting for adverse events was done for participants during active participation and for 4 months following completion

ArmDeathsSerious adverse eventsOther adverse events
Group I (Prostate Cancer Information)0/121 (0.0%)0/121 (0.0%)0/121 (0.0%)
Group II (General Health Information)0/118 (0.0%)0/118 (0.0%)0/118 (0.0%)

+Locations (1)

FacilityCityCountryStatus
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphia, PennsylvaniaUnited States

+Study documents

+Investigators

My Notes